NGR peptide structure
|
Common Name | NGR peptide | ||
---|---|---|---|---|
CAS Number | 651328-78-8 | Molecular Weight | 608.69200 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H36N10O8S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of NGR peptideNGR peptide containing the Asn-Gly-Arg (NGR) motif. NGR peptide binds to APN/CD13. NGR peptide is directly conjugated to imaging agents that can be used for tumor imaging[1][2]. |
Name | 2-[[(2R)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[(2R)-2-amino-3-sulfanylpropanoyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-sulfanylpropanoyl]amino]acetic acid |
---|---|
Synonym | More Synonyms |
Description | NGR peptide containing the Asn-Gly-Arg (NGR) motif. NGR peptide binds to APN/CD13. NGR peptide is directly conjugated to imaging agents that can be used for tumor imaging[1][2]. |
---|---|
Related Catalog | |
Target |
CD13/aminopeptidase N (APN) receptor[1] |
In Vivo | NGR peptide (20 mg/kg; i.v.) 可用作肿瘤成像和早期诊断的潜在 SPECT 试剂[2]。 Animal Model: 4-6 weeks, BALB/c nude mice (HepG2 tumor model)[2] Dosage: 20 mg/kg Administration: I.v. Result: Blocked the tumor uptake for 99mTc-NGR. |
References |
Molecular Formula | C20H36N10O8S2 |
---|---|
Molecular Weight | 608.69200 |
Exact Mass | 608.21600 |
PSA | 409.85000 |
LogP | 1.32580 |
NGR peptide |
Glycine,L-cysteinyl-L-asparaginylglycyl-L-arginyl-L-cysteinyl |